Disruption of the alveolar septal barrier leads to acute lung injury, patchy alveolar flooding, and hypoxemia. Although calcium entry into endothelial cells is critical for loss of barrier integrity, the cation channels involved in this process have not been identified. We hypothesized that activation of the vanilloid transient receptor potential channel TRPV4 disrupts the alveolar septal barrier. Expression of TRPV4 was confirmed via immunohistochemistry in the alveolar septal wall in human, rat, and mouse lung. In isolated rat lung, the TRPV4 activators 4␣-phorbol-12,13didecanoate and 5,6-or 14,15-epoxyeicosatrienoic acid, as well as thapsigargin, a known activator of calcium entry via store-operated channels, all increased lung endothelial permeability as assessed by measurement of the filtration coefficient, in a dose-and calcium-entry dependent manner. The TRPV antagonist ruthenium red blocked the permeability response to the TRPV4 agonists, but not to thapsigargin. Light and electron microscopy of rat and mouse lung revealed that TRPV4 agonists preferentially produced blebs or breaks in the endothelial and epithelial layers of the alveolar septal wall, whereas thapsigargin disrupted interendothelial junctions in extraalveolar vessels. The permeability response to 4␣-phorbol-12,13-didecanoate was absent in TRPV4 Ϫ/Ϫ mice, whereas the response to thapsigargin remained unchanged. Collectively, these findings implicate TRPV4 in disruption of the alveolar septal barrier and suggest its participation in the pathogenesis of acute lung injury. (Circ Res. 2006;99:988-995.) 
A cute lung injury and its more severe form the adult respiratory distress syndrome are characterized by disruption of the alveolar septal barrier, leading to patchy alveolar flooding and hypoxemia. 1 Effective clinical treatments are limited and mortality remains high. 2, 3 Such endothelial barrier disruption is often dependent on entry of Ca 2ϩ from the extracellular space. 4, 5 For example, in the intact rat lung, thapsigargin-induced store depletion and Ca 2ϩ entry via store-operated channels increase endothelial permeability. 6, 7 Store depletion targets extraalveolar vessel endothelium, although the septal microvasculature appears to be spared. 7, 8 Although endothelial cells derived from extraalveolar pulmonary arteries and septal microvessels are phenotypically distinct 9, 10 and both could potentially be targeted in acute lung injury, disruption of the septal barrier is more likely to promote alveolar flooding and impair gas exchange than disruption in extraalveolar vessels. Importantly, Ca 2ϩ entry pathways involved in regulation of barrier integrity in the alveolar septal compartment have not been elucidated.
The consensus of data suggests that TRPC1 and TRPC4, members of the canonical subfamily of transient receptor potential (TRP) channels, [11] [12] [13] [14] [15] comprise subunits of store-operated Ca 2ϩ channels in lung endothelium. 16 -18 In the isolated rat lung, the permeability response to thrombininduced store depletion was attenuated in TRPC4 Ϫ/Ϫ mice. 18 Furthermore, loss of the permeability response to thapsigargin-induced store depletion in rat lung after heart failure was associated with downregulation of TRPC1 and TRPC4, channels which are normally expressed in extraalveolar endothelium. 19 Retention of the permeability response to 14,15-epoxyeicosatrienoic acid (14, , a P450 epoxygenase-derived arachidonic acid metabolite, in this heart failure model was intriguing because the permeability responses to both thapsigargin-induced store depletion and to 14,15-EET are dependent on Ca 2ϩ entry. This striking observation drives home the point that EETs must target Ca 2ϩ entry pathways in lung endothelium distinct from store-operated channels.
We propose that Ca 2ϩ entry via TRPV4, a member of the vanilloid subfamily of TRP channels, 13,20 -24 contributes critically to regulation of endothelial permeability and barrier integrity in the lung. This hypothesis is based on several observations: 5,6-EET and 8,9-EET have been linked to activation of TRPV4 and subsequent Ca 2ϩ entry in aortic endothelial cells, 25,26 5,6-EET and 14,15-EET increase endothelial permeability in rat and canine lung, 6, 27 and the permeability response to 14,15-EET, at least, is dependent on entry of extracellular Ca 2ϩ . 6 In the current study, we tested the hypothesis that Ca 2ϩ entry via TRPV4 regulates lung endothelial permeability and barrier integrity. Furthermore, we tested whether Ca 2ϩ entry via TRPV4 and that occurring through store-operated channels evoke barrier disruption in spatially distinct compartments of the pulmonary vasculature.
Materials and Methods

Animals
Protocols were approved by our Institutional Animal Care and Use Committee, conforming to the NIH Guide for the Care and Use of Laboratory Animals. Adult male CD rats (nϭ139, Charles River) or 8-to 10-week-old TRPV4 wild-type mice (TRPV4 ϩ/ϩ ) and null littermates (TRPV4 Ϫ/Ϫ ) 28 of either sex (nϭ39) were anesthetized with sodium pentobarbital (50 mg/kg body weight IP). Lungs were isolated for ex vivo perfusion as previously described. 6
TRPV4 Expression
Human lung resection specimens (nϭ3), obtained under a protocol approved by the Institutional Review Board, were fixed by immersion in 10% formalin or 100% ethanol. Rat and mouse lungs (nϭ2 to 3 in each group) were perfusion fixed with 4% paraformaldehyde. Sections (5 m) were processed for immunohistochemistry using a rabbit anti-TRPV4 polyclonal antibody (Alomone), stained with diaminobenzidine and counterstained with hematoxylin. Western blots were prepared from lysates (40 g of total protein) of rat pulmonary artery and microvascular endothelium and TRPV4 detected using enhanced chemiluminescence. Total RNA from mouse lung was reverse transcribed, then PCR performed using primers designed to amplify the pore-loop region of TRPV4 (see the online data supplement, available at http://circres.ahajournals.org).
Microscopic Assessment of Acute Lung Injury
Light microscopy and transmission electron microscopy (EM) were used to evaluate structural changes in glutaraldehyde-fixed lung, 19 after treatment with vehicle (910 L of ethanol), 4␣PDD (3 or 10 mol/L in rat or mouse lung, respectively), 14,15-EET (3 mol/L, rat lung only), or thapsigargin (150 nmol/L) for 60 minutes (nϭ3 per group). Using 1-m thick sections, extraalveolar vessel cuffing and alveolar flooding were evaluated. Cuff frequency and the cuff volume (V c ) fraction of total wall volume (V c /V w ) were determined, the latter using a point-counting strategy. 29 Pointcounting was used to determine alveolar fluid volume (V af ) fraction in the alveolar space (V af /V as ). Thin sections (80 nm) from the same blocks were examined via transmission EM. Junctional discontinuities (gaps), blebs, or breaks in septal capillaries were enumerated. Means for cuff frequency, volume fractions and blebs or breaks per capillary were determined separately for each lung, then overall descriptive statistics derived for each group.
Isolated Lung and Assessment of Endothelial Permeability
Both rat and mouse lungs were perfused at constant flow with buffer (in mmol/L: 116.0 NaCl, 5.2 KCl, 0.9 MgSO 4 , 1.0 Na 2 HPO 4 , 2.2 NaHCO 3 , 8.3 D-glucose) containing 4% BSA and either physiological (2.2 mmol/L) or low (0.02 mmol/L) CaCl 2 at pH 7.4 (38°C). Hemodynamics and the filtration coefficient (K f ) were measured as previously described, 6, 19, 30, 31 using zone 3 conditions. K f was calculated as the rate of weight gain obtained 13 to 15 minutes after a 7 to 10 cmH 2 O increase in pulmonary venous pressure, normalized per g lung dry weight. K f , the product of specific endothelial permeability and surface area for exchange, is a sensitive measure of lung endothelial permeability when surface area is fully recruited. 32
Protocols
In rat lungs perfused with physiological [Ca 2ϩ ], K f and hemodynamics were measured at baseline and 60 minutes after treatment with the TRPV4 agonist 4␣-phorbol-12,13-didecanoate (4␣PDD) (1 to 10 mol/L, nϭ3 per dose) or the TRPV1 agonist 4␣-phorbol-12,13didecanoate-20 homovanillate (4␣PDDHV) (10 mol/L, nϭ4). Using 0.02 mmol/L [Ca 2ϩ ] perfusate, K f and hemodynamics were measured at baseline and 45 minutes after treatment (nϭ5 per group) with 4␣PDD (3 mol/L), 5,6-EET or 14,15-EET (3 mol/L, Biomol), or thapsigargin (150 nmol/L), with or without the TRPV antagonist ruthenium red (1 mol/L). Subsequently, CaCl 2 was added to achieve physiological [Ca 2ϩ ] (Ca 2ϩ add-back), and measurements repeated 15 minutes later. Lungs isolated from TRPV4 Ϫ/Ϫ mice or wild-type littermates (nϭ4 to 5 per group) were perfused with buffer containing 4% albumin and physiological [Ca 2ϩ ]. K f and hemodynamics were measured baseline and 60 minutes after treatment with vehicle (50 L DMSO), 4␣PDD (10 mol/L), or thapsigargin (150 nmol/L). Vehicle controls in rat lungs (nϭ5 each) included ethanol (910 L or 2%) or DMSO (50 L or 0.1%); DMSO was also evaluated in lungs from wild-type mice (nϭ4). All drugs were added to the perfusate; final circulating concentrations are noted.
Statistical Analysis
Quantitative data are presented as meanϮSEM. Group means were compared using a paired t test (2 tailed) or ANOVA, as appropriate; the Newman-Keuls multiple comparison test was used to identify specific differences. Probability values of Ͻ0.05 were considered statistically significant.
Results
Baseline Parameters in Isolated Rat and Mouse Lung
Total pulmonary vascular resistance, the distribution of vascular resistance and baseline K f were similar in rat and mouse lungs ( Table 1 ) and were not impacted by the choice of perfusate [Ca 2ϩ ]. There were no differences with respect to baseline measurements between TRPV4 ϩ/ϩ and TRPV4 Ϫ/Ϫ mice.
Expression of TRPV4 in Lung: Functional Consequences
TRPV4 was expressed in the septal compartment of lungs from humans, rats and mice ( Figure 1A through 1C, respectively), as well as in bronchiolar epithelium (not shown). TRPV4 was also expressed in smooth muscle in human and rat extraalveolar vessels. Although TRPV4 expression in cultured rat pulmonary artery endothelium was similar to that in microvascular endothelium ( Figure 1D ), TRPV4 was not consistently expressed in extraalveolar vessel endothelium in intact lung ( Figure 1A through 1C ). In rat lung, 1, 5, and 10 mol/L 4␣PDD increased K f by 1.7-, 4.2-, and 5.6-fold, respectively ( Figure 1E ), supporting the notion that TRPV4 may play a role in regulating endothelial permeability. In contrast, the TRPV1 agonist 4␣PDDHV had no impact on endothelial permeability despite use of a ϾEC 100 dose. 33 To determine whether activation of TRPV4 increased permeability in a Ca 2ϩ entry-dependent fashion, K f was reevaluated using the low Ca 2ϩ /Ca 2ϩ add-back strategy. The Ca 2ϩ concentration chosen for the low Ca 2ϩ segment of these experiments was based on the lowest concentration that allowed stable K f for at least 1 hour (see the online data supplement). Ca 2ϩ add-back provides a normal inward Ca 2ϩ gradient, and if Ca 2ϩ permeant channels have been activated by the treatment, Ca 2ϩ entry results and endothelial permeability increases. The Ϸ3-fold increase in K f induced by 4␣PDD was clearly dependent on Ca 2ϩ entry ( Figure 2A ) and was blocked by ruthenium red ( Figure 2B ), which potently blocks TRPV4 by binding to an extracellular domain on the channel. 24, 33 We confirmed that the permeability response to 14,15-EET and thapsigargin in rat lung is dose dependent (see the online data supplement) and Ca 2ϩ entry dependent (Figure 2A ) and documented a similar pattern for 5,6-EET (online data supplement and Figure 2A ). At 0.02 mmol/L [Ca 2ϩ ], both 5,6-EET and 14,15-EET evoked a small increase in perme-ability, although Ca 2ϩ add-back was required for the development of the normal permeability response to the EETs. 6 In the absence of Ca 2ϩ add-back, the increase in K f induced by 55, 56 ; Pa, pulmonary artery pressure; Pc, pulmonary capillary pressure; Pv, pulmonary venous pressure; Ra, arterial vascular resistance; Rv, venous vascular resistance; Rt, total vascular resistance.
Figure 1.
Activation of TRPV4 expressed in lung increases endothelial permeability. In human (A), rat (B), and mouse (C) lung, TRPV4 was expressed in the alveolar septal compartment (left panels) and bronchial epithelium (not shown). TRPV4 expression in vascular smooth muscle in extraalveolar vessels (right panels) was observed in human and rat lung, whereas little was seen in mouse lung. Western blotting (D) showed similar TRPV4 expression in rat microvascular (MV) and pulmonary artery (PA) endothelium (TRPV4/␤-actin band density was 1.1 in both groups). However, TRPV4 was not consistently expressed in extraalveolar vessel endothelium in intact lung (A through C). The TRPV4 agonist 4␣PDD (E) increased the filtration coefficient K f in isolated rat lung (Pϭ0.021) in a dose-dependent fashion (Pϭ0.002); *PϽ0.05 vs 1 or 5 mol/L. The TRPV1 agonist 4␣PDDHV had no effect (Pϭ0.201, paired t test).
data supplement). EETs activate large conductance Ca 2ϩ -activated potassium channels (BK Ca ), providing an increased driving gradient for Ca 2ϩ entry. 34, 35 However, blockade of BK Ca channels did not alter the EET-induced permeability response (see the online data supplement).
Compartmentalization of Barrier Disruption
Results of the morphometric analysis from light microscopy ( Figure 3 ) and transmission EM (Figure 4 ) are shown in Table  2 . 4␣PDD and thapsigargin resulted in frequent extraalveolar cuffs in rat (Pϭ0.006), but not in mouse lung, compared with control. Nonetheless, V c /V w was not different between groups in either rat or mouse lung. Activation of TRPV4 resulted in blebs or breaks in septal endothelium in both rat and mouse lung (Pϭ0.009 and Pϭ0.019, respectively, versus control or thapsigargin). Furthermore, the TRPV4 agonists disrupted type I alveolar epithelial cells, manifested as separation of the epithelium from the basal lamina. 4␣PDD increased V af /V as , compared with control and thapsigargin, in both rat and mouse lung (Pϭ0.003 and 0.011, respectively). Whereas 14,15-EET caused significant septal injury, the increase in V af /V as was more variable, and as a result the 4-group ANOVA was not significant. In contrast, thapsigargin primarily targeted interendothelial junctional complexes in extraalveolar vessels, leading to formation of gaps; the septal capillary network was spared, and V af /V as did not increase. Together, these data support the notion that activation of TRPV4 (via 4␣PDD or EETs) and activation of storeoperated channels (via thapsigargin) promote barrier disruption in discrete vascular compartments of the lung even though these agents cause similar increases in total lung K f in a Ca 2ϩ entry-dependent fashion.
The 4␣PDD and EET-mediated permeability responses were inhibited with ruthenium red, a pleiotropic antagonist that blocks TRPV4. Although activation of TRPV1 had no impact on endothelial permeability in rat lung, it was possible that ruthenium red blocked other TRPV isoforms, contributing to its impact on the permeability response. Thus, we used mice genetically engineered for a targeted deletion of exon 12 in the trpv4 gene, 28 encoding the transmembrane domains 5 and 6, which includes the predicted pore loop region of the channel (TRPV4 Ϫ/Ϫ ). Genotyping (see the online data supplement) and PCR ( Figure 5A ) were used to document expression of TRPV4 in wild-type mice. Whereas 3 mol/L 4␣PDD had no impact on permeability in TRPV4 ϩ/ϩ mice, 10 mol/L 4␣PDD increased K f 2.8-fold ( Figure 5B ); this dose did not alter K f in lungs from TRPV4 Ϫ/Ϫ littermates. Thapsigargin increased K f Ϸ3-fold in both TRPV4 ϩ/ϩ and TRPV4 Ϫ/Ϫ mice. These results confirm that activation of TRPV4 increases endothelial permeability in the mouse lung.
Discussion
This study provides the first evidence of a functional role for TRPV4 in lung endothelium, implicating TRPV4 in Ca 2ϩ entry-dependent regulation of endothelial permeability and barrier integrity in the alveolar septal network. Despite similar impact on K f , activation of TRPV4 and store-operated channels led to injury in distinct vascular compartments. Activation of TRPV4 by 4␣PDD and 14,15-EET preferentially targeted the alveolar septal microvessels, whereas thapsigargin-induced store depletion targeted extraalveolar vessels. The TRPV4 agonists typically caused endothelial blebs and/or breaks, whereas thapsigargin induced formation of gaps at endothelial cell junctions. These data suggest that distinct endothelial compartments, and possibly distinct subcellular compartments of lung endothelial cells, must be targeted subsequent to Ca 2ϩ entry via these TRP channels. The observation that the Ca 2ϩ entry-dependent component of the permeability response to 5,6-and 14,15-EET, as well as the TRPV4 agonist 4␣PDD, was ablated by pretreatment of rat lung with ruthenium red suggests an important role for TRPV4 in regulation of lung endothelial permeability. This notion is corroborated by the loss of the permeability response to the TRPV4 agonist 4␣PDD in lungs from TRPV4 Ϫ/Ϫ mice. In light of the critical vulnerability of the alveolar septal barrier in acute lung injury, 2,3 our findings in the rodent models of lung injury and the finding of TRPV4 expression in human alveolar septum lead us to hypothesize that TRPV4 is likely to play a role in the development of acute lung injury and the acute respiratory distress syndrome in humans.
TRP Channels and Permeability
Ca 2ϩ entry into endothelial cells occurs via activation of selective Ca 2ϩ channels or nonselective cation channels, such as those encoded by the large superfamily of TRP channel proteins. Much of the focus in lung endothelium has been on the TRPC subfamily. Endothelial cells express mRNA and protein for TRP channels, including TRPC1, TRPC3, TRPC4, TRPC6, and TRPC7. 14, 36, 37 In rat lung, TRPC1, TRPC3, TRPC4, and TRPC6/7 protein is expressed in endothelium of extraalveolar vessels. Although mRNA for several members of the TRPV subfamily, including TRPV4, are expressed in human pulmonary artery endothelium, 36 only a subset of TRP proteins may actually play a physiological role in regulation of lung endothelial permeability. Two studies have addressed a role for TRPC channels in regulation of permeability in the intact lung. Tiruppathi et al reported a partial loss of the permeability response to thrombin in TRPC4 Ϫ/Ϫ mice, 18 and we recently found that in an aortocaval fistula model of heart failure, endothelial TRPC1 and TRPC4 expression in extraalveolar vessels is downregulated and the by 4␣PDD (B) , 14,15-EET (C), or thapsigargin (D) was heterogeneous (arrows), and cuff volume fraction was no different among groups (see Table 2 ). Alveolar fluid volume fraction was increased by 4␣PDD and 14,15-EET, ( Table 2 ). Scale barsϭ100 m. PA indicates pulmonary arteriole; Br, bronchiole; L, lymphatic. permeability response to thapsigargin is lost. 19 Although Ca 2ϩ entry can occur via receptor-operated TRP channels (TRPC3, TRPC6, and TRPC7), 38 and these channels are indeed expressed in rat lung endothelium, activation of these channels with a diacylglycerol analog had no impact on endothelial permeability in rat lung. 19 A role in regulation of lung endothelial permeability has not been explored for TRP proteins outside the canonical TRP family. Aside from thrombin and thapsigargin, we do not know whether the Ca 2ϩ entry-dependent increases in endothelial permeability are attributable to gating of TRP channels, nor which TRP channels are involved. Our previous work evaluating the impact of EETs, P450 epoxygenase derivatives of arachidonic acid, on lung endothelial permeability in normal rats and rats with chronic heart failure 6, 19 supports the notion of heterogeneity in Ca 2ϩ -dependent regulation of endothelial permeability in lung. P450 epoxygenases metabolize arachidonic acid to form four regioisomers: 5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET. 39 EETs are released from human lung after inflammatory challenge, 40 suggesting their potential involvement in acute lung injury. In canine lung, blockade of EET synthesis attenuated the pulmonary edema and hypoxemia resulting from ethchlorvynol. 41 Furthermore, exogenous 5,6-EET and 14,15-EET increased endothelial permeability in canine and rat lung, 6, 27 in a Ca 2ϩ entry-dependent manner. The notion that EETs must target Ca 2ϩ permeant channels distinct from TRPC1/TRPC4 is based on the following evidence: (1) the permeability response to both EETs and thapsigargin in rat lung requires Ca 2ϩ entry; (2) the response to 14,15-EET was retained after experimentally induced heart failure, although that to store depletion was lost; and (3) TRPC1 and TRPC4 expression were downregulated in extraalveolar vessels from rats with heart failure. 6, 19 Our current results support the notion that TRPV4 expressed in lung septal microvascular endothelium plays a critical role in the permeability response to EETs and 4␣PDD.
Functional Role for TRPV4 Channels in the Alveolar Septal Network
TRPV4, a channel originally described as activated by hypotonicity, 20, 23, 42 appears to participate in detection of changes in extracellular fluid osmolality. 28 Although TRPV channels are appreciated for their role in sensory transduction, [43] [44] [45] [46] nonsensory functions are now recognized. 21, [47] [48] [49] [50] Work from Nilius and colleagues 25, 26, 51 suggests that TRPV4 likely plays a significant role in endothelial Ca 2ϩ signaling. Both 4␣PDD and 5,6-EET activate TRPV4 heterologously expressed in HEK-293 cells as well as endogenous TRPV4 in aortic endothelial cells, promoting Ca 2ϩ entry which was inhibited by ruthenium red. 26 Furthermore, EET-induced Ca 2ϩ entry in aortic endothelial cells was diminished in endothelium derived from TRPV4 Ϫ/Ϫ mice. 25 Collectively, . Activation of TRPV4 increases endothelial permeability in mouse lung. A, Using primers designed to amplify across the pore-loop region of TRPV4 mRNA, the predicted 612-bp product was observed in wild-type and heterozygote mice but not in null animals. B, In isolated mouse lung, we showed that the TRPV4 agonist 4␣PDD (10 mol/L) increased endothelial permeability (K f ) in only TRPV4 ϩ/ϩ mice (Pϭ0.036, paired t test). In contrast, activation of store-operated channels via thapsigargin (150 nmol/L) increased permeability in both wild-type and null mice (Pϭ0.032 and 0.008, respectively, paired t test). These results confirm the role of TRPV4 in mediating acute lung injury. *PϽ0.05 vs baseline (paired t test). these data suggested that TRPV4 could play a role in Ca 2ϩ entry-dependent regulation of endothelial permeability. Our results provide a functional role for TRPV4 expressed in the lung alveolar septal network. The TRPV4 agonist 4␣PDD increased endothelial permeability in rat lung in a Ca 2ϩ entry-dependent fashion. This response, and the Ca 2ϩ entrydependent permeability response to 5,6-and 14,15-EET, could be blocked with ruthenium red. Furthermore, the permeability response to 4␣PDD observed in TRPV4 ϩ/ϩ mice was lacking in TRPV4 Ϫ/Ϫ littermates.
Transmission EM documented that both 4␣PDD and 14,15-EET caused disruption of the alveolar epithelium, in addition to an impact on the septal endothelial barrier, which very likely contributed to the increase in K f and alveolar flooding induced by these TRPV4 agonists. TRPV4 has previously been demonstrated to be expressed in respiratory epithelial cells, [52] [53] [54] although its functional role in bronchiolar or alveolar epithelium in the intact lung has not been clarified. Our results suggest that an exploration of the signaling cascade linking Ca 2ϩ entry via TRPV4 in alveolar type I cells to detachment of those cells from the basement membrane would be informative.
In summary, this work provides critical evidence of a functional role for TRPV4 in regulation of barrier integrity in the lung alveolar septal network. Although Ca 2ϩ entry via store-operated TRP channels causes gap formation in extraalveolar vessels, the functional consequences of barrier disruption in this compartment are likely distinct from those resulting from TRPV4-dependent barrier disruption in the septal compartment. Activation of store-operated channels in extraalveolar endothelium leads to fluid accumulation in perivascular cuffs, although this likely has little impact on alveolar gas exchange. In contrast, disruption of the vulnerable alveolar septal barrier, such as that resulting from Ca 2ϩ influx via TRPV4, leads to alveolar flooding and thus would be predicted to impair gas exchange. Indeed this is a hallmark of acute lung injury. The implication of this work for translational biomedical research is that TRPV4 is likely a novel molecular target for therapeutic intervention in acute lung injury.
